Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension

Journal of Hypertension

Volumn 24, Issue 11, 2006, Pages 2231-2238

  Pietri, Panagiota ^a,b   Vyssoulis, Gregory ^a   Vlachopoulos, Charalambos ^a   Zervoudaki, Alexandra ^a   Gialernios, Theodoros ^a   Aznaouridis, Konstantinos ^a   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Arterial stiffness; Essential hypertension; Inflammation; Wave reflections

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CAROTID ARTERY PULSE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FEMORAL ARTERY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; SEX RATIO;

EID: 33750240087     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000249701.49854.21     Document Type: Article

References (54)

1. Safar ME, London GM, Asmar R, Frohlich ED. Recent advances on large arteries in hypertension. Hypertension 1998; 32:156-161.
2. Stefanadis C, Dernellis J, Vlachopoulos C, Tsioufis C, Tsiamis E, Toutouzas K, et al. Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem. Circulation 1997; 96:1853-1858.
3. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
4. Benetos A, Adamopoulos C, Bureau JM, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207.
5. Hansen TW, Staessen J, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664-670.
6. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113:601-603.
7. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi A, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instabilility. Circulation 1999; 99:855-860.
8. Liuzzo G, Biasucci L, Gallimore JR, Grillo R, Rebuzzi A, Pepys M, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-424.
9. Ridker P, Buring J, Cook N, Rifai N. C reactive protein, the metabolic syndrome and risk of incident cardiovascular events: an 8 year follow-up of 14719 initially healthy American women. Circulation 2003; 107:391-397.
10. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, et al. High sensitivity C- reactive protein as an idependent risk factor for essential hypertension. Am J Hypertens 2003; 16:429-433.
11. Sesso H, Buring J, Rifai N, Blake G, Gaziano J, Ridker P. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290:2945-2951.
12. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflection in healthy individuals. Circulation 2005; 112:2193-2200.
13. Mattace-Raso FU, van der Cammen TJM, van der Meer IM, Schalekamp MA, Asmar R, Hofman A, Witteman JC. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 2004; 176:111-116.
14. Nagano M, Nakamura M, Sato K, Tanaka F, Segawa T, Hiramori K. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 2005; 180:189-195.
15. Kullo I, Seward J, Bailey K, Bielak L, Grossardt B, Sheedy IIP, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005; 18:1123-1129.
16. Yasmin, McEniery C, Wallace S, Mackenzie, Cockcroft J, Wilkinson I. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vascul Biol 2004; 24:969-974.
17. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005; 46:1118-1122.
18. Olsen MH, Christensen MK, Hansen TW, Gustafsson F, Rasmussen S, Wachtell K, et al. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens 2006; 24:655-661.
19. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy adults. Hypertension 2002; 39:197-202.
20. Amar J, Ruidavets J-B, Dit Sollier CB, Bongard V, Boccalon H, Chamontin B, et al. Relationship between CRP and pulse pressure is not mediated by atherosclerosis and aortic stiffness. J Hypertens 2004; 22:349-355.
21. Kampus P, Kals J, Ristimae T, Fischer K, Zilmer M, Teesalu R. High sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons. J Hypertens 2004; 22:1133-1139.
22. Kampus P, Muda P, Kals J, Ristimae T, Fischer K, Teesalu R, Zilmer M. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 2005; (in press) [Epub ahead of print].
23. Van Bortel L, Duprez D, Starmans-Kool M, Safar M, Giannattasio C, Cockcroft J, et al. Clinical Applications of Arterial Stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002; 15:445-452.
24. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117.
25. Vlachopoulos C, Kosmopoulou F, Panagiotakos D, Ioakeimidis N, Alexopoulos N, Pitsavos C, Stefanadis C. Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections. J Am Coll Cardiol 2004; 44:1911-1917.
26. O'Rourke M, Staessen J, Vlachopoulos C, Duprez D, Plante G. Clinical applications of arterial stiffness: definitions and reference values. Am J Hypertens 2002; 15:426-444.
27. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111:3384-3390.
28. Vlachopoulos C, Alexopoulos N, Panagiotakos D, O'Rourke MF, Stefanadis C. Cigar smoking has an acute detrimental effect on arterial stiffness. Am J Hypertens 2004; 17:299-303.
29. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac A-M, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26:485-490.
30. Pauca A, O'Rourke M, Kon N. Prospective evaluation of a method for estimating asceding aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38:932-937.
31. Vlachopoulos C, Hirata K, O'Rourke M. Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: the role of arterial wave reflections. Hypertension 2001; 38:1456-1460.
32. Chae C, Lee R, Rifai N, Ridker P. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38:399-403.
33. Stumpf C, John S, Jukic J, Yilmaz A, Raaz D, Schmieder R, et al. Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 2005; 23:995-1000.
34. Gimbrone MA Jr, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 1997; 99:1809-1813.
35. Torsellini A, Beccuci A, Citi S, Cozzolino F, Guidi G, Lombardi V, et al. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP aggregation. Haematologica 1982; 67:860-866.
36. Kranzhofer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19:1623-1629.
37. Booth AD, Wallace S, McEniery CM, Yasmin, Brown J, Jayne DR, Wilkinson IB. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004; 50:581-588.
38. Yildiz M, Soy M, Kurum T, Ozbay G. Increased pulse wave velocity and shortened pulse wave propagation time in young patients with rheumatoid arthritis. Can J Cardiol 2004; 20:1097-1100.
39. Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003; 62:414-418.
40. Wang C-H, Li S-H, Weisel R, Fedak P, Dumont A, Szmitko P, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107:1783-1790.
41. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-2168.
42. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106:1439-1441.
43. Clapp B, Hirschfield G, Storry C, Gallimore JR, Stidwill R, Singer M, et al. Inflammation and endothelial function. Direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005; 111:1530-1536.
44. Johnson DB, Kip K, Marroquin O, Ridker P, Kelsey S, Shaw L, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women. Circulation 2004; 109:726-732.
45. Nichols WW, O'Rourke MF, editors. McDonald's blood flow in arteries, 4th edn. London: Edward Arnold; 1998. pp.170-222, 284-315, 347-395, 450-476.
46. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor is associated with reduced concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003; 34:2922-2929.
47. Fliser D, Buchholz K, Haller H, the European Trial on Olmesartan and Pravastatin in Inflammation and Atherosclerosis (EUTOPIA) investigators. Antiiflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004; 110:1103-1107.
48. Williams B, Lacy P, Thom S, Cruickshank K, Stanton A, Collier D, for the CAFE Investigators. Anglo-Scandinavian Cardiac Outcomes Trial Investigators; Cafe Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the conduit artery function evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
49. Hirata K, Vlachopoulos C, Adji A, O'Rourke MF. Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': beyond blood pressure or beyond the brachial artery? J Hypertens 2005; 23:551-556.
50. Pannier BM, Guerin AP, Marchais SJ, London GM. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol 2001; 28:1074-1077.
51. Ridker P, Rifai N, Pfeffer M, Sacks F, Moye L, Goldman S, et al. Cholesterol and Recurrent Event (CARE) Investigators. Inflammation, Pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998; 98:839-844.
52. Ridker P, Cushman M, Stampfer MJ, Tracy R, Hennekens C. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
53. Reinehr T, Stoffel-Wagner B, Roth CL, Andler W. High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. Metabolism 2005; 54:1155-1161.
54. Wildman R, Mackey R, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 2003; 42:468-473.